“…According to the literatura, the survival of patients submitted to splenectomy due to metachronous splenic metastases varies from 6 months to 7 years 4,11,12,24 , with average survival of 66.6 months 4,13 ; then, most authors defend the use of splenectomy in the presence of metachronous and isolated metastatic lesion in patients with primary colon cancer, followed or not by chemotherapy 4,9,11,12,14,17,20,23,24 . However, although the literature reports the use of splenectomy in synchronous isolated splenic metastases associated with CRC 4,12,25 , one of the described patients died of peritoneal carcinomatosis one year later and another patient developed secondary liver lesions after the splenectomy.…”